Clinical trialNCT00375739CompletedPhase 2Interventional

Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses

SponsorPeplinEnrollment200Actinic Keratosis

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine whether topical application of PEP005 is safe for the treatment of actinic keratoses.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Lawrence Anderson, Dr
Principal Investigator
clinicaltrials.gov ↗
Peter Welburn, PhD
Sponsor GmbH
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Medical Affiliated Research Center, Inc.
Huntsville, Alabama, United States
Radiant Research
Tucson, Arizona, United States
Burke Pharmaceutical Research
Hot Springs, Arkansas, United States
Advanced Dermatology and Cosmetic Surgery
Clermont, Florida, United States
Dermatology Associates and Research
Coral Gales, Florida, United States
North Florida Dermatology Associates P.A.
Jacksonville, Florida, United States
Park Avenue Dermatology, Pa
Orange Park, Florida, United States
Dermatology Associates of Tallahassee
Tallahassee, Florida, United States
Palm Beach Aesthetics
West Palm Beach, Florida, United States
Medaphase, Inc
Newnan, Georgia, United States
Gwinnett Clinical Research Centre, Inc
Snellville, Georgia, United States
Henry Ford Health Center- Farmington Road
West Bloomfield, Michigan, United States
Academic Dermatology Associates
Albuquerque, New Mexico, United States
Mount Sinai Hospital School of Medicine
New York, New York, United States
St. Luke'S/roosevelt Hospital Center Dermatology
New York, New York, United States
University Dermatology Consultants, Inc., Dermatology Clinical Research Center
Cincinnati, Ohio, United States
Radiant Research
Columbus, Ohio, United States
Oregon Medical Research
Centre9495 Southwest Locust St., Suite G Portland, Oregon, United States
Radiant Research
Anderson, South Carolina, United States
Radiant Research
Greer, South Carolina, United States
Dermatology Clinical Research Center of San Antonio
San Antonio, Texas, United States
Dermatology Associates of Tyler
Tyler, Texas, United States
Dermatology Research Centre
Salt Lake City, Utah, United States
Skokane Dermatology Clinic, Pllp.
Spokane, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

PEP005

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Sept 2006
Primary completion: 30 Jun 2007
Completion: 30 Jun 2007
Last update posted: 28 Jan 2016
Registered enrollment: 200
Registry id: NCT00375739

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.